Glioblastoma multiforme (GBM) and beyond: By-passing the blood brain barrier (BBB) via Tumor Treating Fields (TTFields) in vivo

被引:0
作者
Salvador, E. [1 ]
Kessler, A. [1 ]
Hoermann, J. [1 ]
Burek, M. [2 ]
Brami, C. Tempel [3 ]
Sela, T. Voloshin [3 ]
Giladi, M. [3 ]
Ernestus, R. I. [1 ]
Loehr, M. [1 ]
Foerster, C. [2 ]
Hagemann, C. [1 ]
机构
[1] Univ Wurzburg, Dept Neurosurg, Tumorbiol Lab, Wurzburg, Germany
[2] Univ Wurzburg, Div Mol Med, Dept Anesthesia & Crit Care, Wurzburg, Germany
[3] Novocure Ltd, Haifa, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P02-8
引用
收藏
页码:S81 / S82
页数:2
相关论文
共 50 条
[21]   QUALITY OF LIFE (QOL) MANAGEMENT OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AND CHEMOTHERAPY. [J].
Saria, Marlon Garzo ;
Carter, Joshua ;
Kesari, Santosh ;
Orosco, Heather ;
Turpin, Tiffany ;
Piccioni, David .
ONCOLOGY NURSING FORUM, 2016, 43 (02) :18-19
[22]   Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM) [J].
Cappelli, L. ;
Kanyne, A. ;
Pan, P. C. ;
Cordova, J. S. ;
Huang, J. ;
Wang, T. J. C. ;
Alnahhas, I. ;
Shi, W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03) :E68-E68
[23]   TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) [J].
Lazaridis, Lazaros ;
Schaefer, Niklas ;
Kebir, Sied ;
Weller, Johannes ;
Tzaridis, Theophilos-Dimitrios ;
Scheffler, Bjoern ;
Pierscianek, Daniela ;
Kleinschnitz, Christoph ;
Stuschke, Martin ;
Sure, Ulrich ;
Herrlinger, Ulrich ;
Glas, Martin .
NEURO-ONCOLOGY, 2018, 20 :119-120
[24]   Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) [J].
Lazaridis, L. ;
Kebir, S. ;
Weller, J. ;
Tzaridis, T. -D ;
Scheffler, B. ;
Pierscianek, D. ;
Kleinschnitz, C. ;
Stuschke, M. ;
Sure, U. ;
Herrlinger, U. ;
Schaefer, N. ;
Glas, M. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 :S109-S109
[25]   TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) [J].
Lazaridis, L. ;
Schaefer, N. ;
Kebir, S. ;
Weller, J. ;
Tzaridis, T. ;
Schaeffler, B. ;
Pierscianek, D. ;
Kleinschnitz, C. ;
Stuschke, M. ;
Sure, U. ;
Herrlinger, U. ;
Glas, M. .
NEURO-ONCOLOGY, 2018, 20 :230-230
[26]   ASSESSMENT OF TUMOR TREATING FIELDS (TTFIELDS) COMBINED WITH TRICHOSTATIN A (TSA) IN PATIENT-DERIVED GLIOBLASTOMA (GBM) CELLS [J].
Ma, Manxiu ;
Michelhaugh, Sharon ;
Mittal, Sandeep .
NEURO-ONCOLOGY, 2021, 23 :35-35
[27]   Tumor treating fields effects on the blood-brain barrier in vitro and in vivo. [J].
Salvador, Ellaine ;
Kessler, Almuth ;
Hoermann, Julia ;
Domroese, Dominik ;
Schaeffer, Clara ;
Burek, Malgorzata ;
Tempel-Brami, Catherine ;
Voloshin, Tali ;
Giladi, Moshe ;
Ernestus, Ralf-Ingo ;
Loehr, Mario ;
Foerster, Carola ;
Hagemann, Carsten .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[28]   CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) [J].
Cappelli, Louis ;
Kayne, Allison ;
Pan, Peter ;
Cordova, James ;
Huang, Jiayi ;
Wang, Tony ;
Alnahhas, Iyad ;
Shi, Wenyin .
NEURO-ONCOLOGY, 2022, 24 :53-53
[29]   B IN VIVO EFFICACY OF TUMOR TREATING FIELDS (TTFIELDS) FOR GLIOBLASTOMA USING NOVEL MOUSE HEAD ARRAYS [J].
Zbidat, S. ;
Blatt, R. ;
Sellevoll, M. ;
Gabay, M. ;
Schlachet, I ;
Cahal, S. ;
Davidi, S. ;
Tzchori, I ;
Haber, A. ;
Giladi, M. ;
Palti, Y. .
NEURO-ONCOLOGY, 2024, 26
[30]   Designing arrays for the mouse head to facilitate in vivo studies of Tumor Treating Fields (TTFields) treatment of glioblastoma [J].
Zbidat, Sewar ;
Blatt, Roni ;
Sellevoll, Mariell ;
Gabay, Martin ;
Schlachet, Inbar ;
Cahal, Shay ;
Davidi, Shiri ;
Tzchori, Itai ;
El-Mabhouh, Amal ;
Haber, Adi ;
Giladi, Moshe ;
Palti, Yoram .
CANCER RESEARCH, 2024, 84 (05)